CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members (original) (raw)

• Bignell, G. R. et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nature Genet. 25, 160–165 (2000)
  Article CAS Google Scholar
• Ghosh, S. & Karin, M. Missing pieces in the NF-κB puzzle. Cell 109, S81–S96 (2002)
  Article CAS Google Scholar
• Jain, A. et al. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nature Immunol. 2, 223–228 (2001)
  Article CAS Google Scholar
• Wilkinson, K. D. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J. 11, 1245–1256 (1997)
  Article CAS Google Scholar
• Headon, D. J. & Overbeek, P. A. Involvement of a novel TNF receptor homologue in hair follicle induction. Nature Genet. 22, 370–374 (1999)
  Article CAS Google Scholar
• Yan, M. et al. Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors. Science 290, 523–527 (2000)
  Article ADS CAS Google Scholar
• Hatzivassiliou, E. & Mosialos, G. Cellular signaling pathways engaged by the Epstein-Barr virus transforming protein LMP1. Front. Biosci. 7, d319–d329 (2002)
  Article CAS Google Scholar
• Nguyen, L. T. et al. TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses. Immunity 11, 379–389 (1999)
  Article CAS Google Scholar
• Lomaga, M. A. et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13, 1015–1024 (1999)
  Article CAS Google Scholar
• Yan, M. et al. Identification of a novel death domain-containing adaptor molecule for ectodysplasin-A receptor that is mutated in crinkled mice. Curr. Biol. 12, 409–413 (2002)
  Article CAS Google Scholar
• Naito, A. et al. TRAF6-deficient mice display hypohidrotic ectodermal dysplasia. Proc. Natl Acad. Sci. USA 99, 8766–8771 (2002)
  Article ADS CAS Google Scholar
• Kaye, K. M. et al. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-κB activation by latent infection membrane protein 1, the Epstein–Barr virus transforming protein. Proc. Natl Acad. Sci. USA 93, 11085–11090 (1996)
  Article ADS CAS Google Scholar
• Schultheiss, U. et al. TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1. EMBO J. 20, 5678–5691 (2001)
  Article CAS Google Scholar
• Deng, L. et al. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351–361 (2000)
  Article CAS Google Scholar
• Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346–351 (2001)
  Article ADS CAS Google Scholar
• Shi, C. S. & Kehrl, J. H. Tumor necrosis factor (TNF)-induced germinal center kinase-related (GCKR) and stress-activated protein kinase (SAPK) activation depends upon the E2/E3 complex Ubc13-Uev1A/TNF receptor-associated factor 2 (TRAF2). J. Biol. Chem. 278, 15429–15434 (2003)
  Article CAS Google Scholar
• McKenna, S. et al. An NMR-based model of the ubiquitin-bound human ubiquitin conjugation complex Mms2-Ubc13. The structural basis for lysine 63 chain catalysis. J. Biol. Chem. 278, 13151–13158 (2003)
  Article CAS Google Scholar
• Devin, A. et al. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 12, 419–429 (2000)
  Article CAS Google Scholar
• Devin, A. et al. The α and β subunits of IκB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF. Mol. Cell. Biol. 21, 3986–3994 (2001)
  Article CAS Google Scholar
• Zhang, S. Q., Kovalenko, A., Cantarella, G. & Wallach, D. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKγ) upon receptor stimulation. Immunity 12, 301–311 (2000)
  Article CAS Google Scholar
• Hu, M. et al. Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 111, 1041–1054 (2002)
  Article CAS Google Scholar
• Karin, M., Cao, Y., Greten, F. R. & Li, Z. W. NF-κB in cancer: from innocent bystander to major culprit. Nature Rev. Cancer 2, 301–310 (2002)
  Article CAS Google Scholar
• Brummelkamp, T. R., Nijman, S. M. B., Dirac, A. M. G. & Bernards, R. Loss of cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB. Nature 424, 797–801 (2003)
  Article ADS CAS Google Scholar
• Mosialos, G. et al. The Epstein–Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80, 389–399 (1995)
  Article CAS Google Scholar
• Mitchell, T. & Sugden, B. Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein–Barr virus. J. Virol. 69, 2968–2976 (1995)
  CAS PubMed PubMed Central Google Scholar
• Hatzivassiliou, E., Cardot, P., Zannis, V. I. & Mitsialis, S. A. Ultraspiracle, a Drosophila retinoic X receptor α homologue, can mobilize the human thyroid hormone receptor to transactivate a human promoter. Biochemistry 36, 9221–9231 (1997)
  Article CAS Google Scholar
• Devergne, O. et al. Association of TRAF1, TRAF2, and TRAF3 with an Epstein–Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF- κB activation. Mol. Cell. Biol. 16, 7098–7108 (1996)
  Article CAS Google Scholar